<scp>Long‐Term</scp> Outcomes and Prognosis Factors in Patients With Idiopathic Inflammatory Myopathies Based on <scp>Myositis‐Specific</scp> Autoantibodies: A Single Cohort Study

Abstract

Despite favorable overall survival in patients with IIM, the anti-MDA-5-positive subgroup had the highest mortality rate among all MSA subgroups, highlighting the distinctive prognosis for patients with different MSAs. RP-ILD and malignancy are the most common causes of death in IIM patients.